Katrien Grunberg - Radboudumc | 人才画像

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 183 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table S1 from Maximizing Treatment Opportunities: Assessing Protocol Waivers’ Impact on Safety and Outcome in the Drug Rediscovery Protocol

Jade M. van Berge Henegouwen,Laurien J. Zeverijn,Birgit S. Geurts,Louisa R. Hoes,Hanneke van der Wijngaart,Vincent van der Noort,Alwin D.R. Huitema,Filip Y.F. de Vos,Katrien Grünberg,Haiko J. Bloemendal,Henk M.W. Verheul,Emile E. Voest,Hans Gelderblom

crossref（2024）

引用0浏览0引用

Comparing Deep Learning and Pathologist Quantification of Cell-Level PD-L1 Expression in Non-Small Cell Lung Cancer Whole-Slide Images

Leander van Eekelen, Joey Spronck,Monika Looijen-Salamon,Shoko Vos,Enrico Munari,Ilaria Girolami,Albino Eccher,Balazs Acs,Ceren Boyaci, Gabriel Silva de Souza, Muradije Demirel-Andishmand, Luca Dulce Meesters, Daan Zegers,Lieke van der Woude,Willemijn Theelen,Michel van den Heuvel,Katrien Grünberg,Bram van Ginneken,Jeroen van der Laak,Francesco Ciompi

Scientific Reportsno. 1 (2024)

引用0浏览0WOSNATURE引用

Making Pathologists Ready for the New AI Era: Changes in Required Competencies

Shoko Vos,Konnie Hebeda,Megan Milota,Martin Sand,Jojanneke Drogt,Katrien Grünberg,Karin Jongsma

Modern pathology an official journal of the United States and Canadian Academy of Pathology, Incno. 2 (2024): 100657-100657

引用0浏览0WOS引用

Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery Protocol

Jade M. van Berge Henegouwen,Laurien J. Zeverijn,Birgit S. Geurts,Louisa R. Hoes,Hanneke van der Wijngaart,Vincent van der Noort,Alwin D. R. Huitema,Filip Y. F. de Vos,Katrien Grunberg,Haiko J. Bloemendal,Henk M. W. Verheul,Emile E. Voest,Hans Gelderblom

Clinical Cancer Research (2024)

引用0浏览0WOS引用

Supplementary Table S3 from Maximizing Treatment Opportunities: Assessing Protocol Waivers’ Impact on Safety and Outcome in the Drug Rediscovery Protocol

crossref（2024）

引用0浏览0引用

Supplementary Table S2 from Maximizing Treatment Opportunities: Assessing Protocol Waivers’ Impact on Safety and Outcome in the Drug Rediscovery Protocol

crossref（2024）

引用0浏览0引用

Supplementary Table S4 from Maximizing Treatment Opportunities: Assessing Protocol Waivers’ Impact on Safety and Outcome in the Drug Rediscovery Protocol

crossref（2024）

引用0浏览0引用

Supplementary Data from Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma In situ

Pyng Lee,Remco M. van den Berg,Stephen Lam,Adi F. Gazdar,Katrien Grunberg,Annette McWilliams,Jean LeRiche,Pieter E. Postmus,Tom G. Sutedja

crossref（2023）

引用0浏览0引用

1723P Improving Access to Molecular Tumour Boards for Complex Genomic Profiles: A Healthcare Policy from the Netherlands

S. van Waalwijk van Doorn-Khosrovani, C. Reparon,S. Koole, A. Huisman, C. Louis, M. Van Aart, W. Groenen,K. Grunberg,E. Schuuring,V. T. H. B. M. Smit,K. Monkhorst, H. Gelderblom, S. van der Flier

ANNALS OF ONCOLOGY (2023): S938-S938

引用0浏览0引用

1710P Protocol Waivers and Consequences on Treatment Safety and Efficacy in the Drug Rediscovery Protocol (DRUP)

L. J. Zeverijn,J. M. Van Berge Henegouwen,B. S. Geurts,G. F. de Wit,L. Hoes,H. van der Wijngaart,V. van der Noort,A. D. R. Huitema,F. Y. F. L. De Vos,K. Grunberg,H. Bloemendal,H. M. W. Verheul,E. E. Voest,H. Gelderblom

ANNALS OF ONCOLOGY (2023): S933-S933

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn